A successful model for making more out of physics for development is ready to roll out to others, writes Dipali Bhatt-Chauhan.

Ten years after introducing a Biodiversity Act, India is yet to put it to serious use, say Shalini Bhutani and Kanchi Kohli.

The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says Priya Shetty.

Implementation of the Rio+20 outcome must account for changes in the global innovation landscape, says tech policy expert Ahmed Abdel-Latif.

Technology transfer is a priority for a new phase in China–Africa cooperation — but it needs the right direction, says Linda Nordling.

Two safeguards for communities' rights to resources can help implement the Nagoya Protocol, argues biodiversity specialist Krystyna Swiderska.

Current models of innovation ignore small-scale technology — institutions must ensure it's a key part of the agenda, says Tony Marjoram.

New models of intellectual property rights are needed to protect — and promote — local knowledge and innovations, says Anil Gupta.

Trade deals are threatening generic drugs — we need new ways to incentivise affordable drug development, says health expert Daniele Dionisio.

There is a pressing need for Africa to bolster its pharmaceuticals industry, and that requires the right policy framework, argues Priya Shetty.

African governments with technology policies that focus only on ICT should rethink their priorities, says Ndubuisi Ekekwe.

Impact studies warn that TRIPS-Plus provisions can lead to higher prices and reduced access to medicines, say Nusaraporn Kessomboon and colleagues.

Prizes for innovation must be used carefully to ensure that poor people in developing countries are the real winners, says Matthew Harsh.

African innovation won't flourish unless more attention is paid to creating and sustaining markets for it, argues Linda Nordling.

Both fake and substandard medicines threaten public health, and efforts to tackle them must put the focus on quality, says Leena Menghaney.

Developing countries should turn down the UN biodiversity convention proposals to nationalise genetic resources, argue Indian scientists.

To make an impact, science and technology must embrace Africa's informal system of making and trading, argues Steve Daniels.

Climate scientists and organisations should lead the way to open-source collaborations, say Brendan Barrett and Sulayman K. Sowe.

To boost commercialisation of research developing nations must carve out policies that suit their own needs, argues Bhaven N. Sampat.